Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55 SEK | +6.59% | -0.72% | +20.48% |
May. 02 | Integrum Expands Its Product Offering to the United Kingdom Market | CI |
Mar. 26 | Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel | CI |
Sales 2024 * | 107M 9.87M | Sales 2025 * | 151M 13.93M | Capitalization | 1.01B 93.52M |
---|---|---|---|---|---|
Net income 2024 * | 3M 277K | Net income 2025 * | 15M 1.38M | EV / Sales 2024 * | 9.27 x |
Net cash position 2024 * | 22.09M 2.04M | Net cash position 2025 * | 18.81M 1.73M | EV / Sales 2025 * | 6.59 x |
P/E ratio 2024 * |
1,375
x | P/E ratio 2025 * |
73.7
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.11% |
1 day | +6.59% | ||
1 week | -0.72% | ||
Current month | -3.85% | ||
1 month | +7.84% | ||
3 months | +33.82% | ||
6 months | +51.31% | ||
Current year | +20.48% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 97-12-31 | |
Jörgen Svanström
DFI | Director of Finance/CFO | - | 23-05-01 |
Mats Dotevall
COO | Chief Operating Officer | 62 | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-12-31 | |
Bengt Sjöholm
CHM | Chairman | 71 | 18-12-31 |
Founder | 64 | 97-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 55 | +6.59% | 52,677 |
24-05-08 | 51.6 | +0.78% | 6,692 |
24-05-07 | 51.2 | -1.92% | 28,061 |
24-05-06 | 52.2 | -5.78% | 96,619 |
24-05-03 | 55.4 | -4.15% | 42,649 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.48% | 93.56M | |
-12.06% | 20.97B | |
-1.49% | 17.77B | |
+7.25% | 13.85B | |
+8.24% | 10.07B | |
-8.16% | 2.3B | |
+5.65% | 1.79B | |
+33.51% | 1.64B | |
+20.00% | 625M | |
0.00% | 390M |
- Stock Market
- Equities
- INTEG B Stock